182 related articles for article (PubMed ID: 25527419)
21. A positive feedback loop between STAT3 and cyclooxygenase-2 gene may contribute to Helicobacter pylori-associated human gastric tumorigenesis.
Xiong H; Du W; Sun TT; Lin YW; Wang JL; Hong J; Fang JY
Int J Cancer; 2014 May; 134(9):2030-40. PubMed ID: 24127267
[TBL] [Abstract][Full Text] [Related]
22. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
[TBL] [Abstract][Full Text] [Related]
23. The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function.
Yan YX; Li WZ; Huang YQ; Liao WX
Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):29-35. PubMed ID: 21835258
[TBL] [Abstract][Full Text] [Related]
24. [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
Ran JT; Zhou YN; Tang CW; Lu JR; Wu J; Lu H; Yang GD
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):448-51. PubMed ID: 19024521
[TBL] [Abstract][Full Text] [Related]
25. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimäki A
Cancer Res; 2003 Jun; 63(12):3032-6. PubMed ID: 12810622
[TBL] [Abstract][Full Text] [Related]
27. Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis.
Nardone G; Rocco A; Vaira D; Staibano S; Budillon A; Tatangelo F; Sciulli MG; Perna F; Salvatore G; Di Benedetto M; De Rosa G; Patrignani P
J Pathol; 2004 Mar; 202(3):305-12. PubMed ID: 14991895
[TBL] [Abstract][Full Text] [Related]
28. Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide.
Huang MT; Chen ZX; Wei B; Zhang B; Wang CH; Huang MH; Liu R; Tang CW
Acta Pharmacol Sin; 2007 Nov; 28(11):1842-50. PubMed ID: 17959037
[TBL] [Abstract][Full Text] [Related]
29. Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model.
Kuo CH; Hu HM; Tsai PY; Wu IC; Yang SF; Chang LL; Wang JY; Jan CM; Wang WM; Wu DC
World J Gastroenterol; 2009 Oct; 15(39):4907-14. PubMed ID: 19842220
[TBL] [Abstract][Full Text] [Related]
30. Eosinophil infiltration, gastric juice and serum eosinophil cationic protein levels in Helicobacter pylori-associated chronic gastritis and gastric ulcer.
Aydemir SA; Tekin IO; Numanoglu G; Borazan A; Ustundag Y
Mediators Inflamm; 2004 Dec; 13(5-6):369-72. PubMed ID: 15770055
[TBL] [Abstract][Full Text] [Related]
31. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
Nam KT; Hahm KB; Oh SY; Yeo M; Han SU; Ahn B; Kim YB; Kang JS; Jang DD; Yang KH; Kim DY
Clin Cancer Res; 2004 Dec; 10(23):8105-13. PubMed ID: 15585646
[TBL] [Abstract][Full Text] [Related]
32. Effects of Helicobacter pylori Infection on gastric mucin expression.
Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
[TBL] [Abstract][Full Text] [Related]
33. Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells.
Liu H; Huang P; Xu X; Liu J; Guo C
Dig Dis Sci; 2009 Jul; 54(7):1418-24. PubMed ID: 18923901
[TBL] [Abstract][Full Text] [Related]
34. [The inhibitive effects of celecoxib combined with octreotide on the metastasis of human gastric cancer in vivo].
Huang MT; Chen ZX; Wei B; Zhang B; Wang CH; Huang MH; Tang CW
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3255-9. PubMed ID: 17313803
[TBL] [Abstract][Full Text] [Related]
35. Long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia After H. pylori eradication.
Sheu BS; Tsai YC; Wu CT; Chang WL; Cheng HC; Yang HB
Helicobacter; 2013 Apr; 18(2):117-23. PubMed ID: 23067366
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
38. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer.
Bartchewsky W; Martini MR; Masiero M; Squassoni AC; Alvarez MC; Ladeira MS; Salvatore D; Trevisan M; Pedrazzoli J; Ribeiro ML
Scand J Gastroenterol; 2009; 44(2):153-61. PubMed ID: 18985541
[TBL] [Abstract][Full Text] [Related]
39. Chemopreventive effect of celecoxib in gastric cancer.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Ueki N; Kusunoki M; Miyake K; Gudis K; Tsukui T; Sakamoto C
Inflammopharmacology; 2007 Feb; 15(1):1-4. PubMed ID: 17323186
[TBL] [Abstract][Full Text] [Related]
40. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
